{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:43:23Z","timestamp":1791467003037,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.euroneuro.2023.12.006","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T12:32:09Z","timestamp":1703248329000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-880X","authenticated-orcid":false,"given":"Marcelo","family":"Falchi-Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-2565","authenticated-orcid":false,"given":"Isabel","family":"Wie\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-0439","authenticated-orcid":false,"given":"S\u00e9rgio Ruschi B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-1938","authenticated-orcid":false,"given":"Lucas","family":"O\uff0e\u202fMaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handersson","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Laborde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Arichelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Tullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natan","family":"Silva-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Assun\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3687-8790","authenticated-orcid":false,"given":"Raissa","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-6207","authenticated-orcid":false,"given":"\u00c9rica J.","family":"Pantrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-3979","authenticated-orcid":false,"given":"Raynara","family":"Bolcont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Victor","family":"Costa-Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2001-4536","authenticated-orcid":false,"given":"Emerson","family":"Arcoverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4887-8635","authenticated-orcid":false,"given":"Nicole","family":"Galv\u00e3o-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-2485","authenticated-orcid":false,"given":"Draulio B.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1612-6703","authenticated-orcid":false,"given":"Fernanda","family":"Palhano-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2023.12.006_bib0001","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5214\/ans.0972.7531.12190210","article-title":"Serotonin and CGRP in migraine","volume":"19","author":"Aggarwal","year":"2012","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0002","series-title":"Psychedelic Integration: Psychotherapy for Non-Ordinary States of Consciousness","author":"Aixal\u00e0","year":"2022"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0003","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2545","article-title":"Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens","author":"Bouso","year":"2016","journal-title":"Hum. Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0005","doi-asserted-by":"crossref","DOI":"10.47626\/1516-4446-2022-0042","article-title":"Interventional psychiatry: 13 reasons why","author":"Brunoni","year":"2022","journal-title":"Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999)"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0006","first-page":"342","article-title":"Blood pressure response to moderate physical activity is increased in obesity","volume":"67","author":"Burger","year":"2009","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0008","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0010","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D'Souza","year":"2022","journal-title":"Neuropsychopharmacology: off. publ. Am. College Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0012","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0013","first-page":"20","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","author":"Francescangeli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0014","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/15622975.2015.1132007","article-title":"Assessment and management of agitation in psychiatry: expert consensus","volume":"17","author":"Garriga","year":"2016","journal-title":"World J. Biol. Psychiatry: Off. J. World Federat. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0015","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2005-916185","article-title":"Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers","volume":"38","author":"Gouzoulis-Mayfrank","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0017","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/jps.20574","article-title":"Evaluation of a vaporizing device (Volcano\u00ae) for the pulmonary administration of tetrahydrocannabinol","volume":"95","author":"Hazekamp","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0018","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology: Off. Publ. Am. College Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0019","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0020","article-title":"The content of complex psychedelic experiences resulting from inhalation of N, N-dimethyltryptamine","author":"Kagan","year":"2022","journal-title":"J. Psychedelic Stud."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0021","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1038\/s41598-022-11999-8","article-title":"Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience","volume":"12","author":"Lawrence","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0022","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0023","first-page":"1","article-title":"Indigenous and mestizo use of ayahuasca: an overview","author":"Luna","year":"2011","journal-title":"Ethnopharmacol. Ayahuasca"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0024","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euroneuro.2022.10.008","article-title":"Ayahuasca's therapeutic potential: what we know - and what not","volume":"66","author":"Maia","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/02791072.2018.1557355","article-title":"Effect of ritualistic consumption of ayahuasca on hepatic function in chronic users","volume":"51","author":"Mello","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0026","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.1902174116","article-title":"Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America","volume":"116","author":"Miller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0028","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0101-60832011000600004","article-title":"Hallucinogen Rating Scale (HRS) - Vers\u00e3o brasileira: tradu\u00e7\u00e3o e adapta\u00e7\u00e3o transcultural","volume":"38","author":"Mizumoto","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib47","series-title":"Transplantation Proceedings","first-page":"1268","article-title":"N-dimethyltryptamine prevents renal ischemia-reperfusion injury in a rat model","volume":"51","author":"Nemes","year":"2019"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0029","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"de Os\u00f3rio","year":"2015","journal-title":"Revista brasileira de psiquiatria"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0031","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0032","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0269881120981384","article-title":"Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings","volume":"35","author":"Pallavicini","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.760671","article-title":"A phase 1, dose-ranging study to assess safety and psychoactive effects of a vaporized 5-Methoxy-N, N-Dimethyltryptamine formulation (GH001) in healthy volunteers","volume":"12","author":"Reckweg","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0034","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jnc.15587","article-title":"The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)","volume":"162","author":"Reckweg","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","volume":"154","author":"Riba","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0036","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0037","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0038","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0039","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02157378","article-title":"Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism","volume":"12","author":"Szara","year":"1956","journal-title":"Experientia"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0040","first-page":"201","article-title":"DMT at fifty","volume":"9","author":"Sz\u00e1ra","year":"2007","journal-title":"Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja=official journal of the Hungarian Association of Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0041","first-page":"97","article-title":"Melatonin and serotonin effects. scholar.archive.org","volume":"58","author":"Thor","year":"2007","journal-title":"J. Physiol. Pharmacol.: Off. J. Polish Physiol. Soc."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0042","doi-asserted-by":"crossref","first-page":"16324","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.12.006_bib0043","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41398-023-02477-4","article-title":"Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants","volume":"13","author":"Vogt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0044","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0045","first-page":"1","article-title":"LSD, madness and healing: mystical experiences as possible link between psychosis model and therapy model","author":"Wie\u00dfner","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2023.12.006_bib0046","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euroneuro.2023.09.007","article-title":"Methodological concerns in psychedelic research: the issues of nonequivalent psychological support and generalizability","volume":"78","author":"Zeifman","year":"2023","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23007307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23007307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:07:32Z","timestamp":1760378852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X23007307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":46,"alternative-id":["S0924977X23007307"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.12.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}